Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study
Authors:
- For The German Neonatal Network (Gnn)F(For The German Neonatal Network (Gnn)
- Egbert HertingEHEgbert Herting
Open Access
- 18 February 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 179 (8) , 1309-1313
Abstract
Less invasive surfactant administration (LISA) is a method to deliver surfactant to spontaneously breathing premature infants via a thin catheter. Here we report the two-year outcome from the AMV (avoid mechanical ventilation) study, the first randomized controlled trial on this mode of surfactant delivery. No statistically significant differences in weight, length or neurodevelopmental outcome (Bayley II scores) were found between the LISA intervention group (n = 95) and the control group (n = 84) that received standard treatment.Conclusion: No differences in outcome were observed at 2 years. LISA seems safe in that aspect. What is Known:• LISA is a method that is in increasing use for surfactant delivery to spontaneously breathing infants. LISA reduces the need for mechanical ventilation. What is New:• Outcome data at 2 years from the first randomized study with LISA raise no safety concerns in comparison to a group of infants that received standard treatment.Keywords
Funding Information
- BMBF (01ER0805 and 01ER1501)
This publication has 15 references indexed in Scilit:
- Review demonstrates that less invasive surfactant administration in preterm neonates leads to fewer complicationsActa Paediatrica, 2018
- Neurodevelopmental outcome in very preterm and very‐low‐birthweight infants born over the past decade: a meta‐analytic reviewDevelopmental Medicine & Child Neurology, 2018
- European perspective on less invasive surfactant administration—a surveyEuropean Journal of Pediatrics, 2016
- Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm InfantsJAMA, 2016
- Observational Study on Less Invasive Surfactant Administration (LISA) in Preterm Infants<29 Weeks – Short and Long-term OutcomesZeitschrift für Geburtshilfe und Neonatologie, 2015
- Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm InfantsJAMA Pediatrics, 2015
- Less Invasive Surfactant Administration (LISA) — Ways to deliver surfactant in spontaneously breathing infantsEarly Human Development, 2013
- Less Invasive Surfactant Administration in Extremely Preterm Infants: Impact on Mortality and MorbidityNeonatology, 2013
- Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trialThe Lancet, 2011
- Surfactant in spontaneous breathing with nCPAP: neurodevelopmental outcome at early school age of infants ≤27 weeksActa Paediatrica, 2010